DIA DEEP DIVE: Opportunities in Oncology
First of its kind breast cancer treatment wins FDA approval: PI3K inhibitor treatment demonstrates clinically meaningful benefit, in combination with hormone therapy, for postmenopausal women (and men) with a specific type of advanced breast cancer.